Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

313 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Phase II Trial of the PARP Inhibitor, Niraparib, in BAP1 and Other DNA Damage Response Pathway-Deficient Neoplasms.
George TJ, Lee JH, DeRemer DL, Hosein PJ, Staal S, Markham MJ, Jones D, Daily KC, Chatzkel JA, Ramnaraign BH, Close JL, Ezenwajiaku N, Murphy MC, Allegra CJ, Rogers S, Zhang Z, Li D, Srinivasan G, Shaheen M, Hromas R. George TJ, et al. JCO Precis Oncol. 2024 Dec;8:e2400406. doi: 10.1200/PO-24-00406. Epub 2024 Dec 3. JCO Precis Oncol. 2024. PMID: 39626160 Free PMC article. Clinical Trial.
Synthetic lethality in malignant pleural mesothelioma with PARP1 inhibition.
Srinivasan G, Sidhu GS, Williamson EA, Jaiswal AS, Najmunnisa N, Wilcoxen K, Jones D, George TJ Jr, Hromas R. Srinivasan G, et al. Among authors: george tj jr. Cancer Chemother Pharmacol. 2017 Oct;80(4):861-867. doi: 10.1007/s00280-017-3401-y. Epub 2017 Jul 29. Cancer Chemother Pharmacol. 2017. PMID: 28756516 Free PMC article.
Immunotherapy Management in Special Cancer Patient Populations.
Ramnaraign BH, Chatzkel JA, Al-Mansour ZA, Rogers S, Jones D, DeRemer D, George TJ. Ramnaraign BH, et al. Among authors: george tj. JCO Oncol Pract. 2021 May;17(5):240-245. doi: 10.1200/OP.20.00996. Epub 2021 Mar 12. JCO Oncol Pract. 2021. PMID: 33710933 Review.
Administration of Immune Checkpoint Inhibitors Near the End of Life.
Bloom MD, Saker H, Glisch C, Ramnaraign B, George TJ, Markham MJ, Kelkar AH. Bloom MD, et al. Among authors: george tj. JCO Oncol Pract. 2022 Jun;18(6):e849-e856. doi: 10.1200/OP.21.00689. Epub 2022 Mar 7. JCO Oncol Pract. 2022. PMID: 35254868
Clinical Updates for Colon Cancer Care in 2022.
Fabregas JC, Ramnaraign B, George TJ. Fabregas JC, et al. Among authors: george tj. Clin Colorectal Cancer. 2022 Sep;21(3):198-203. doi: 10.1016/j.clcc.2022.05.006. Epub 2022 Jun 3. Clin Colorectal Cancer. 2022. PMID: 35729033 Review.
A nurse-led intervention in patients with newly diagnosed cancer and Type 2 diabetes: A pilot randomized controlled trial feasibility study.
Scarton L, Nelson T, Jo A, O'Neal LJ, Yao Y, Huggins S, Legaspi AB, McClaren MJ, Cabassa JS, Burgos Melendez JM, Munoz-Pena JM, Markham MJ, Murphy MC, Chatzkel JA, Rogers S, George TJ. Scarton L, et al. Among authors: george tj. Cancer Med. 2023 Jun;12(11):12874-12880. doi: 10.1002/cam4.6118. Epub 2023 May 22. Cancer Med. 2023. PMID: 37212484 Free PMC article. Clinical Trial.
313 results